| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/THX.2007.094912 |
| P698 | PubMed publication ID | 19252018 |
| P2093 | author name string | W-H Hsu | |
| B-S Huang | |||
| C-C Hsieh | |||
| Y-C Wu | |||
| M-H Huang | |||
| J-S Liu | |||
| J-J Hung | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | non-small-cell lung carcinoma | Q3658562 |
| P304 | page(s) | 192-196 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | Thorax | Q7796158 |
| P1476 | title | Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence | |
| P478 | volume | 64 |
| Q38790915 | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer |
| Q36195562 | CT Characteristic of Early Local Recurrence After Resection of the Squamous Cell Carcinoma: Comparison With CT Characteristics of Stump Deformity or Granulation Tissue at Stump Site |
| Q89863315 | Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer |
| Q55347427 | Completion pneumonectomy: a valuable option for lung cancer recurrence or new primaries. |
| Q35996056 | Cons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancer |
| Q64899007 | Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA). |
| Q33762059 | Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma |
| Q50128100 | Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling. |
| Q52989702 | FDG uptake at the bronchial stump after curative lobectomy for non-small cell lung cancer. |
| Q37629018 | Factors predicting organ-specific distant metastasis in patients with completely resected lung adenocarcinoma |
| Q58121598 | Giant cell carcinoma of the lung successfully treated with surgical resection and adjuvant vinorelbine and cisplatin |
| Q36619063 | Growth-stimulatory activity of TIMP-2 is mediated through c-Src activation followed by activation of FAK, PI3-kinase/AKT, and ERK1/2 independent of MMP inhibition in lung adenocarcinoma cells |
| Q91728611 | Healthcare utilisation in general practice and hospitals in the year preceding a diagnosis of cancer recurrence or second primary cancer: a population-based register study |
| Q37002744 | Isolated brain metastasis as a late recurrence of completely resected non-small cell lung cancer |
| Q57452854 | Local cancer recurrence: The realities, challenges, and opportunities for new therapies |
| Q30411297 | Local recurrence following lung cancer surgery: incidence, risk factors, and outcomes |
| Q33583923 | Long-term outcomes after salvage radiotherapy for postoperative locoregionally recurrent non-small-cell lung cancer |
| Q36140911 | Longitudinal study on circulating miRNAs in patients after lung cancer resection. |
| Q36817059 | Lung cancer prognosis before and after recurrence in a population-based setting |
| Q64092967 | Overexpression of Aiolos promotes epithelial-mesenchymal transition and cancer stem cell-like properties in lung cancer cells |
| Q54541339 | Overexpression of T-LAK cell-originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma. |
| Q36596567 | Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer |
| Q38021143 | Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis |
| Q35200427 | Post-therapeutic positron emission tomography/computed tomography for early detection of non-small cell lung cancer recurrence |
| Q37567804 | Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status |
| Q36540289 | Prediction and prognostic factors of post-recurrence survival in recurred patients with early-stage NSCLC who underwent complete resection |
| Q36205492 | Predictors of Recurrence after Curative Resection in Patients with Early-Stage Non-Small Cell Lung Cancer |
| Q34633138 | Predictors of imaging surveillance for surgically treated early-stage lung cancer |
| Q36682970 | Prevention of lung cancer recurrence using cisplatin-loaded superhydrophobic nanofiber meshes |
| Q42783628 | Prognosis of recurrence after complete resection in early-stage non-small cell lung cancer |
| Q37652622 | Prognosis of recurrent non-small cell lung cancer following complete resection |
| Q59132360 | Prognostic significance of AKR1B10 in patients with resected lung adenocarcinoma |
| Q61807866 | Prognostic significance of basal versus superior segment in patients with completely resected lung adenocarcinoma in the lower lobe |
| Q47353436 | Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer |
| Q35591365 | Salvage stereotactic body radiotherapy for locally recurrent non-small cell lung cancer after sublobar resection and i(125) vicryl mesh brachytherapy |
| Q90697953 | Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: A single-institution analysis of 59 patients |
| Q35742165 | Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival |
| Q37701727 | Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma |
| Q38771929 | Special topics in immunotherapy and radiation therapy: reirradiation and palliation |
| Q41522621 | Survival significance of epidermal growth factor receptor tyrosine kinase inhibitors and current staging system for survival after recurrence in patients with completely resected lung adenocarcinoma |
| Q39458588 | TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer. |
| Q34322658 | The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis |
| Q55024912 | Treatment redirection from cure to palliation, then cure again?-a cautious, but urgent matter. |
Search more.